CCL18 and chronic obstructive pulmonary disease: More importantly, they upregulated immunosuppressive factors (e.g., CCL18, IL1RN, CD274, IL4I1, and IDO1) in COPD airways, which can inhibit T cell proliferation and effector function (91–94).